User profiles for David Guzman

DAVID GUZMAN

- Verified email at student.okaloosaschools.com - Cited by 8336

David M Guzman

- Verified email at micron.com - Cited by 767

Clinical picture and treatment of 2212 patients with common variable immunodeficiency

…, WID Dutch, RT van Beem, D Guzman… - Journal of Allergy and …, 2014 - Elsevier
Background Common variable immunodeficiency (CVID) is an antibody deficiency with an
equal sex distribution and a high variability in clinical presentation. The main features include …

Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale

TP Giordano, D Guzman, R Clark, ED Charlebois… - HIV clinical …, 2004 - Taylor & Francis
Purpose: To examine the performance of an instrument to assess adherence based on a
visual analogue scale, compared to an instrument based on 3-day recall, using unannounced …

Adherence–resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness

DR Bangsberg, EP Acosta, R Gupta, D Guzman… - Aids, 2006 - journals.lww.com
Objective: To compare the prevalence of resistance by adherence level in patients treated
with non-nucleoside reverse transcriptase inhibitors (NNRTI) or protease inhibitors (PI). Also …

High levels of adherence do not prevent accumulation of HIV drug resistance mutations

…, SG Deeks, S Perry, KN Conroy, R Clark, D Guzman… - Aids, 2003 - journals.lww.com
Objectives: To assess the relationship between development of antiretroviral drug resistance
and adherence by measured treatment duration, virologic suppression, and the rate of …

[HTML][HTML] Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels

JJ Parienti, M Das-Douglas, V Massari, D Guzman… - PloS one, 2008 - journals.plos.org
Background While the relationship between average adherence to HIV potent antiretroviral
therapy is well defined, the relationship between patterns of adherence within adherence …

Cost-effectiveness of PCSK9 inhibitor therapy in patients with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease

…, DA Ollendorf, SD Pearson, JA Tice, D Guzman… - Jama, 2016 - jamanetwork.com
Importance Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors were recently
approved for lowering low-density lipoprotein cholesterol in heterozygous familial …

[HTML][HTML] Cost-effectiveness of hypertension therapy according to 2014 guidelines

…, KY Tzong, PW Rasmussen, D Guzman… - … England Journal of …, 2015 - Mass Medical Soc
Background On the basis of the 2014 guidelines for hypertension therapy in the United
States, many eligible adults remain untreated. We projected the cost-effectiveness of treating …

Exhaustion of food budgets at month's end and hospital admissions for hypoglycemia

HK Seligman, AF Bolger, D Guzman, A López… - Health …, 2014 - healthaffairs.org
One in seven US households cannot reliably afford food. Food budgets are more frequently
exhausted at the end of a month than at other points in time. We postulated that this monthly …

[HTML][HTML] Occurrence and characteristics of chronic pain in a community-based cohort of indigent adults living with HIV infection

C Miaskowski, JM Penko, D Guzman, JE Mattson… - The Journal of …, 2011 - Elsevier
Pain is common among people living with HIV/AIDS (PLWHA), but little is known about
chronic pain in socioeconomically disadvantaged HIV-infected populations with high rates of …

Atomic origin of ultrafast resistance switching in nanoscale electrometallization cells

N Onofrio, D Guzman, A Strachan - Nature materials, 2015 - nature.com
Nanoscale resistance-switching cells that operate via the electrochemical formation and
disruption of metallic filaments that bridge two electrodes are among the most promising …